Margaret Wooddell

Rosiglitazone Decreases Bone Mineral Density and Increases Bone Turnover in Postmenopausal Women With Type 2 Diabetes Mellitus

John P. Bilezikian, Robert G. Josse, Richard Eastell et al. · The Journal of Clinical Endocrinology & Metabolism · 2013 · 99 citations · Full text

Medicine, Endocrinology, Bone Augmentation +16

Effects of rosiglitazone added to submaximal doses of metformin compared with dose escalation of metformin in type 2 diabetes: the EMPIRE Study

Peter N. Weissman, B. J. Goldstein, J Rosenstock et al. · Current Medical Research and Opinion · 2005 · 71 citations

Pharmacy, Pharmacology, Pharmacotherapy +16

40th EASD Annual Meeting of the European Association for the Study of Diabetes

M. Veitenhansl, K. Stegner, F. X. Hierl et al. · Diabetologia · 2004 · 68 citations · Full text

Medicine, Endocrinology, Diabetology +11

EpiPen4Schools pilot survey: Occurrence of anaphylaxis, triggers, and epinephrine administration in a U.S. school setting

Martha V. White, S. Hogue, M. Elizabeth Bennett et al. · Allergy and Asthma Proceedings · 2015 · 53 citations

Life Sciences, Health Education, Pediatrics +13

Reductions in biomarkers of cardiovascular risk in type 2 diabetes with rosiglitazone added to metformin compared with dose escalation of metformin: an EMPIRE trial sub-study

Barry J. Goldstein, Peter N. Weissman, Margaret Wooddell et al. · Current Medical Research and Opinion · 2006 · 19 citations

Medicine, Pharmacology, Pharmacotherapy +17